About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 208912, 10 pages
http://dx.doi.org/10.1155/2013/208912
Research Article

Modification of a Rodent Hindlimb Model of Secondary Lymphedema: Surgical Radicality versus Radiotherapeutic Ablation

1Department of Surgery, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea
2Department of Surgery, Seoul National University Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 463-707, Republic of Korea
3Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 156-707, Republic of Korea
4Department of Surgery, Chosun University Hospital, Chosun University College of Medicine, Gwangju 501-717, Republic of Korea

Received 11 July 2013; Revised 7 September 2013; Accepted 9 September 2013

Academic Editor: Monica Fedele

Copyright © 2013 Hyung Sub Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Szuba and S. G. Rockson, “Lymphedema: classification, diagnosis and therapy,” Vascular Medicine, vol. 3, no. 2, pp. 145–156, 1998. View at Scopus
  2. J. E. Zuther, Lymphedema Management: The Comprehensive Guide for Practitioners, Thieme, New York, NY, USA, 2nd edition, 2009.
  3. W. S. Shin, A. Szuba, and S. G. Rockson, “Animal models for the study of lymphatic insufficiency,” Lymphatic Research and Biology, vol. 1, no. 2, pp. 159–169, 2003. View at Scopus
  4. B. Delius, Uber die Regeneration der Lymphdrusen [Dissertation], 1888, quoted by A. W. Meyer, “An experimental study on the recurrence of lymphatic glands and the regeneration of lymphatic vessels in the dog,” Bulletin of the Johns Hopkins Hospital, vol. 17, p. 185, 1906.
  5. C. Hadamitzky and R. Pabst, “Acquired lymphedema: an urgent need for adequate animal models,” Cancer Research, vol. 68, no. 2, pp. 343–345, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. R. Casley Smith, L. Clodius, and M. Foldi, “Experimental blood vascular and lymphatic occlusion in the rabbit ear and the effect of benzopyrones,” Arzneimittel-Forschung, vol. 27, no. 2, pp. 379–382, 1977. View at Scopus
  7. T. Tammela and K. Alitalo, “Lymphangiogenesis: molecular Mechanisms and Future Promise,” Cell, vol. 140, no. 4, pp. 460–476, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. H. S. Park, S. Hahn, G. H. Choi, Y. S. Yoo, J. Y. Lee, and T. Lee, “Muscle-Derived stem cells promote angiogenesis and attenuate intimal hyperplasia in different murine vascular disease models,” Stem Cells and Development, vol. 22, no. 6, pp. 866–877, 2013.
  9. H. S. Park, G. H. Choi, S. Hahn, Y. S. Yoo, J. Y. Lee, and T. Lee, “Potential role of vascular smooth muscle cell-like progenitor cell therapy in the suppression of experimental abdominal aortic aneurysms,” Biochemical Biophysical Research Communications, vol. 431, no. 2, pp. 326–331, 2013. View at Publisher · View at Google Scholar
  10. W. Olszewski, Z. Machowski, J. Sokolowski, and J. Nielubowicz, “Experimental lymphedema in dogs,” Journal of Cardiovascular Surgery, vol. 9, no. 2, pp. 178–183, 1968. View at Scopus
  11. G.-Y. Wang and S.-Z. Zhong, “A model of experimental lymphedema in rats' limbs,” Microsurgery, vol. 6, no. 4, pp. 204–210, 1985. View at Scopus
  12. L. Lee-Donaldson, M. H. Witte, M. Bernas, C. L. Witte, D. Way, and B. Stea, “Refinement of a rodent model of peripheral lymphedema,” Lymphology, vol. 32, no. 3, pp. 111–117, 1999. View at Scopus
  13. M. A. Kanter, S. A. Slavin, and W. Kaplan, “An experimental model for chronic lymphedema,” Plastic and Reconstructive Surgery, vol. 85, no. 4, pp. 573–580, 1990. View at Scopus
  14. S. K. Das, J. D. Franklin, B. M. O'Brien, and W. A. Morrison, “A practical model of secondary lymphedema in dogs,” Plastic and Reconstructive Surgery, vol. 68, no. 3, pp. 422–428, 1981. View at Scopus
  15. H.-C. Chen, J. J. Pribaz, B. M. O'Brien, K. R. Knight, and W. A. Morrison, “Creation of distal canine limb lymphedema,” Plastic and Reconstructive Surgery, vol. 83, no. 6, pp. 1022–1026, 1989. View at Scopus
  16. C. Conrad, H. Niess, R. Huss et al., “Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo,” Circulation, vol. 119, no. 2, pp. 281–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. G. Rockson, “Lymphedema,” American Journal of Medicine, vol. 110, no. 4, pp. 288–295, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Tabibiazar, L. Cheung, J. Han et al., “Inflammatory manifestations of experimental lymphatic insufficiency,” PLoS Medicine, vol. 3, no. 7, article e254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Ristimäki, K. Narko, B. Enholm, V. Joukov, and K. Alitalo, “Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C,” Journal of Biological Chemistry, vol. 273, no. 14, pp. 8413–8418, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Mouta and M. Heroult, “Inflammatory triggers of lymphangiogenesis,” Lymphatic research and biology, vol. 1, no. 3, pp. 201–218, 2003. View at Scopus
  21. A. Szuba, M. Skobe, M. J. Karkkainen et al., “Therapeutic lymphangiogenesis with human recombinant VEGF-C,” The FASEB Journal, vol. 16, no. 14, pp. 1985–1987, 2002. View at Scopus
  22. Y.-S. Yoon, T. Murayama, E. Gravereaux et al., “VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema,” Journal of Clinical Investigation, vol. 111, no. 5, pp. 717–725, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Saito, H. Nakagami, R. Morishita et al., “Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis,” Circulation, vol. 114, no. 11, pp. 1177–1184, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Cao, M. A. Björndahl, P. Religa et al., “PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis,” Cancer Cell, vol. 6, no. 4, pp. 333–345, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. B. M. Deasy, R. J. Jankowski, and J. Huard, “Muscle-derived stem cells: characterization and potential for cell-mediated therapy,” Blood Cells, Molecules, and Diseases, vol. 27, no. 5, pp. 924–933, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Liersch, F. Nay, L. Lu, and M. Detmar, “Induction of lymphatic endothelial cell differentiation in embryoid bodies,” Blood, vol. 107, no. 3, pp. 1214–1216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Kono, H. Kubo, C. Shimazu et al., “Differentiation of lymphatic endothelial cells from embryonic stem cells on OP9 stromal cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 9, pp. 2070–2076, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Harada, T. Yamazaki, C. Iwata et al., “Identification of targets of Prox1 during in vitro vascular differentiation from embryonic stem cells: functional roles of HoxD8 in lymphangiogenesis,” Journal of Cell Science, vol. 122, no. 21, pp. 3923–3930, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. H. Hwang, I. G. Kim, J. Y. Lee et al., “Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel,” Biomaterials, vol. 32, no. 19, pp. 4415–4423, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. B. M. Deasy, B. M. Gharaibeh, J. B. Pollett et al., “Long-term self-renewal of postnatal muscle-derived stem cells,” Molecular Biology of the Cell, vol. 16, no. 7, pp. 3323–3333, 2005. View at Publisher · View at Google Scholar · View at Scopus